MollyBookner

Molly Bookner

Content Marketing Manager
Molly Bookner joined IMO Health as a Content Marketing Manager in 2024. Growing up with two physicians – an ER doctor and a pediatrician – Molly has always been fascinated by health topics and passionate about improving the industry. An inquisitive person by nature and a writer at heart, she earned a Master of Science in Journalism from Northwestern University in 2023, with a focus on digital storytelling. When she’s not writing or editing words, Molly can usually be found cursing under her breath in Pilates class, sampling new restaurants across the city, or filming yet another video of her silly cat, Jinx.

More from Molly Bookner

CMS and HHS both use HCCs for risk adjustment, but with different rules, timing, and populations. Learn the key distinctions for 2025.
The gap between rare disease research and care is vast, leading to long diagnostic journeys – especially for pediatric patients. Structured data can help.
Half of U.S. rare disease patients are children – yet most face delayed diagnoses and few treatment options. Here’s how structured data can change that.
The addition of USCDI v3 and v4 to IMO Health’s proprietary lexicon ensures health systems comply with rapidly evolving regulations, avoiding costly penalties.
Explore value-based care news from June 2025: CMS updates, new risk models, leadership shifts, and tech-driven prevention strategies.
Discover how AI agents can automate scientific literature review, reducing analysis time from hours to minutes for faster insights and better cancer care.
At ISPOR 2025, experts explored how GenAI is helping close evidence gaps in rare diseases – turning messy data into reliable, reproducible insights.
Learn how AI is fortifying predictive analytics, from increased accuracy to streamlined workflows.
Missed the latest in clinical NLP? Our May roundup covers key developments fueling smarter, faster, and more data-driven healthcare decisions.
Structured data is transforming rare disease care – accelerating diagnoses, unifying records, and improving trial recruitment.
At a recent online event, healthcare leaders gathered to discuss the importance of timely, accurate HCC capture for higher revenue and better outcomes.
IMO Health’s Rajiv Haravu joined a recent xCures podcast episode to share how clinical NLP can help solve real problems in health tech and life sciences.